|
Hiltebrand, D., Dey, M., Bolliger, H., & Schaub, M. P. (2018). Heroingestützte Behandlung in der Schweiz : Resultate der Erhebung 2017 (Schweizer Institut für Sucht- und Gesundheitsforschung, Ed.). Zürich: Schweizer Institut für Sucht- und Gesundheitsforschung (ISGF).
Keywords: annual report; questionnaire; treatment and maintenance; heroin-assisted treatment; outpatient care; statistical data; AOD consumption; health; viral hepatitis; HIV infection
|
|
|
Hiltebrand, D., Dey, M., Bolliger, H., & Schaub, M. P. (2018). Traitement avec prescription d’héroïne en suisse : résultats de l’enquête 2017 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Zurich: Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Keywords: annual report; questionnaire; treatment and maintenance; heroin-assisted treatment; outpatient care; statistical data; AOD consumption; health; viral hepatitis; HIV infection
|
|
|
Hiltebrand, D., Dey, M., Bolliger, H., & Schaub, M. P. (2017). Traitement avec prescription d’héroïne en suisse : résultats de l’enquête 2016 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Zurich: Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Keywords: annual report; questionnaire; treatment and maintenance; heroin-assisted treatment; outpatient care; statistical data; AOD consumption; health; viral hepatitis; HIV infection
|
|
|
Hiltebrand, D., Dey, M., Mayorova, E., Bolliger, H., & Schaub, M. P. (2016). Traitement avec prescription d’héroïne en suisse : résultats de l’enquête 2015 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Keywords: annual report; questionnaire; treatment and maintenance; heroin-assisted treatment; outpatient care; statistical data; AOD consumption; health; viral hepatitis; HIV infection
|
|
|
Hiltebrand, D., Dickson-Spillmann, M., Bolliger, H., & Schaub, M. P. (2015). Traitement avec prescription d'héroïne en Suisse : résultats de l'enquête 2014 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Zurich: Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Keywords: annual report; questionnaire; treatment and maintenance; heroin-assisted treatment; outpatient care; statistical data; AOD consumption; health; viral hepatitis; HIV infection
|
|
|
Hälg, R., & Neuner-Jehle, S. (2016). Lust statt Frust beim Reden über Alkohol. Schweizerische Ärztezeitung, 97(36), 1216–1218.
Keywords: AOD consumption; AOD dependence; alcohol abuse; addiction; primary health care; early identification; early intervention; brief intervention; indicated prevention; secondary prevention
|
|
|
Hälg, R., & Neuner-Jehle, S. (2016). Parler d’alcool en toute décontraction, sans frustration. Bulletin des médecins suisses, 97(36), 1216–1218.
Keywords: AOD consumption; AOD dependence; alcohol abuse; addiction; primary health care; early identification; early intervention; brief intervention; indicated prevention; secondary prevention
|
|
|
various. (2012). Drugnet Europe No. 77 : EMCDDA-Europol amphetamine review : range of tools needed to counter threat of emerging drugs : first European quality standards to improve drug prevention in the EU : EMCDDA 2012 work programme: new developmental areas supplement core analysis : Romania passes law to curb distribution of new psychoactive substances : European summer school in illicit drugs : new EMCDDA products and services : quality of EMCDDA outputs commended. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 17(77; 01/2012), 8.
Keywords: AOD use, abuse, and dependence; amphetamines; psychoactive substances; HIV infection; prevention; quality control; laws and regulations; illicit drug; newsletter; European Monitoring Centre for Drugs and Drug Addiction (body)
|
|
|
Jahangir, A., Fuentes, C., Gaviria, C., Zedillo, E., Cardoso, F. H., Papandreou, G., et al. (2011). War on drugs : report of the Global Commission on Drug Policy. Rio de Janeiro: Global Commission on Drug Policy (GCDP).
Abstract: The global war on drugs has failed, with devastating consequences for individuals and societies around the world. Fifty years after the initiation of the UN Single Convention on Narcotic Drugs, and 40 years after President Nixon launched the US government’s war on drugs, fundamental reforms in national and global drug control policies are urgently needed. Vast expenditures on criminalization and repressive measures directed at producers, traffickers and consumers of illegal drugs have clearly failed to effectively curtail supply or consumption. Apparent victories in eliminating one source or trafficking organization are negated almost instantly by the emergence of other sources and traffickers. Repressive efforts directed at consumers impede public health measures to reduce HIV/AIDS, overdose fatalities and other harmful consequences of drug use. Government expenditures on futile supply reduction strategies and incarceration displace more cost-effective and evidence-based investments in demand and harm reduction.
Keywords: AOD use, abuse, and dependence; HIV infection; harm reduction; public policy on AOD; recommendations or guidelines; law enforcement; violence; drug decriminalization; case study; international area; Switzerland; United Kingdom; Netherlands; Portugal; United States; Australia; West Africa; report
|
|
|
various. (2012). Drugnet Europe No. 80 : EMCDDA annual report 2012 highlights : 4-MA – new drug under scrutiny in the wake of deaths : record number of online shops selling 'legal highs' : heroin use in decline and shifting patterns of problem drug use : 'testing the waters' : 2013 conference : 2012 EMCDDA scientific paper award winners : new EMCDDA products and services : annual report 2012 (continued). Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 17(80; 11/2012), 8.
Keywords: AODR mortality; methamphetamines; MDMA; AOD sales outlet; opioids in any form; heroin; AOD use, abuse, and dependence; AOD use pattern; water pollution; annual report; international area; Europe; European Union; European Monitoring Centre for Drugs and Drug Addiction (body); newsletter
|
|